Survivorship Care Plan for Prostate Cancer
Recruiting in Palo Alto (17 mi)
+2 other locations
Age: 18+
Sex: Male
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Emory University
No Placebo Group
Trial Summary
What is the purpose of this trial?This clinical trial compares the impact of a tailored survivorship care plan (SCP) to a standard SCP on the understanding of and access to survivorship care in black or African American patients with prostate cancer that has not spread to other parts of the body (localized) or that has spread from where it first started (primary site) to a limited number of places in the body (oligometastatic). SCPs summarize treatment history and recommendations for monitoring and maintaining health, and may also include potential long term effects of treatments received. The intention of a SCP is to help patients participate in their own health care. However, many patients have below basic levels of health literacy, meaning, they have a lower ability to obtain, communicate, process and understand basic health information and services to make health decisions. In fact, poor health literacy has been linked with worse quality of life in prostate cancer survivors. A tailored SCP includes the addition of an educational supplement based on lower reading and writing skills (low literacy) and may address health literacy barriers to understanding of treatment options and side effects. A standard SCP uses a template based on the American Society of Clinical Oncology (ASCO) guidelines for prostate cancer. A tailored SCP with low literacy educational supplements may be more effective compared to a standard SCP in improving understanding and access to survivorship care in black or African American patients with localized or oligometastatic prostate cancer.
How is the Survivorship Care Plan treatment different from other prostate cancer treatments?
The Survivorship Care Plan (SCP) is unique because it focuses on helping prostate cancer survivors transition from active treatment to follow-up care, improving communication between patients and their healthcare providers, and ensuring continuity of care, rather than directly treating the cancer itself.
13578Is the Survivorship Care Plan safe for humans?
The available research on Survivorship Care Plans (SCPs) does not specifically address safety concerns, as SCPs are primarily documents used to guide follow-up care and improve communication between healthcare providers and patients.
13458What data supports the effectiveness of the treatment Tailored Survivorship Care Plan, Survivorship Care Plan, SCP for prostate cancer?
Survivorship care plans (SCPs) are designed to help cancer survivors manage their health after treatment by providing a summary of their treatment and a follow-up care plan. While there is limited research specifically on SCPs for prostate cancer, studies on SCPs for other cancers suggest they can improve communication and coordination of care between patients and healthcare providers.
12346Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it mentions that patients still receiving adjuvant androgen deprivation therapy can participate, suggesting that some medications may be continued.
Eligibility Criteria
This trial is for Black or African American patients with prostate cancer that's either localized or has spread to a few other places (oligometastatic). It aims to help those who may struggle with health literacy, which means they find it hard to understand and act on medical information.Exclusion Criteria
My prostate cancer has come back after initial treatment.
I am under 18 years old.
I am being treated for another type of cancer.
Participant Groups
The study compares two types of survivorship care plans (SCPs): a standard one based on ASCO guidelines and a tailored version designed for easier understanding by people with lower reading skills. The goal is to see if the tailored SCP improves patient comprehension and access to ongoing healthcare.
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (standard SCP, tailored SCP)Experimental Treatment4 Interventions
Patients receive standard SCP during a provider visit and a tailored SCP with a low literacy educational supplement during a structured interview over 30-60 minutes.
Group II: Group II (standard SCP)Active Control3 Interventions
Patients receive standard SCP using the prostate cancer ASCO template during a provider visit and undergo a structured interview over 30-60 minutes.
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Emory University Hospital/Winship Cancer InstituteAtlanta, GA
Grady Memorial HospitalAtlanta, GA
Atlanta VA Medical CenterAtlanta, GA
Loading ...
Who is running the clinical trial?
Emory UniversityLead Sponsor
United States Department of DefenseCollaborator
National Cancer Institute (NCI)Collaborator
References
Qualitative evaluation of care plans for Canadian breast and head-and-neck cancer survivors. [2022]Survivorship care plans (scps) have been recommended as a way to ease the transition from active cancer treatment to follow-up care, to reduce uncertainty for survivors in the management of their ongoing health, and to improve continuity of care. The objective of the demonstration project reported here was to assess the value of scps for cancer survivors in western Canada.
Guidelines for the use of survivorship care plans: a systematic quality appraisal using the AGREE II instrument. [2022]Survivorship care plans (SCPs) are written treatment summaries and follow-up care plans that are intended to facilitate communication and coordination of care among survivors, cancer care providers, and primary care providers. A growing number of guidelines for the use of SCPs exist, yet SCP use in the United States remains limited. Limited use of SCPs may be due to poor quality of these guidelines. The purpose of the study was to evaluate the quality of guidelines for SCP use, tools that are intended to promote evidence-based medicine.
Primary Care Provider Evaluation of Cancer Survivorship Care Plans Developed for Patients in their Practice. [2022]Survivorship care plans (SCP), which describe a cancer survivor's diagnosis, treatment and follow-up, are recommended. The study objective was to evaluate primary care providers' (PCP) responses to SCPs developed for breast and colorectal cancer survivors in their practice and to determine whether PCP response to the SCPs varied according to characteristics of the practitioner and their practice.
The impact of cancer survivorship care plans on patient and health care provider outcomes: a current perspective. [2017]To help the growing number of cancer survivors deal with the challenges of cancer survivorship, survivorship care plans (SCPs) were recommended by the Institute of Medicine (IOM) in 2006. The SCP is a formal document that contains both a tailored treatment summary and a follow-up care plan. Since the IOM recommendation 10 years ago, the implementation in daily clinical practice is minimal. Several studies have investigated the effects of SCPs on patient-reported outcomes and oncology and primary care providers (PCPs), but the quantity and quality of these studies are limited.
Comparing Web-Based Provider-Initiated and Patient-Initiated Survivorship Care Planning for Cancer Patients: A Randomized Controlled Trial. [2020]Survivorship care plans (SCPs) are intended to facilitate communication and coordination between patients, oncologists, and primary care providers. Most SCP initiatives have focused on oncology providers initiating the SCP process, but time and resource barriers have limited uptake.
Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines? [2020]Survivorship care plans (SCPs) provide key information about cancer treatment history and follow-up recommendations. We describe the completeness of breast cancer SCPs and evaluate guideline concordance of follow-up recommendations.
What are survivorship care plans failing to tell men after prostate cancer treatment? [2021]Survivorship care plans contain important information for patients and primary care physicians regarding appropriate care for cancer survivors after treatment. We describe the completeness of prostate cancer survivorship care plans and evaluate the concordance of follow-up recommendations with guidelines.
Evaluating Internal Medicine Residents' Awareness on Cancer Survivorship Care Plan: A Pilot Survey. [2023]Survivorship care plan (SCP) is a tool to improve communication between oncologists and primary care physicians. Internal medicine residency curricula are lacking training for cancer survivorship and SCPs. Here, we aimed to assess the awareness and utilization of SCPs in medicine trainees.